Genmab A/S buy Lars
Start price
08.11.21
/
50%
€401.20
Target price
08.11.22
-
Performance (%)
-13.86%
End price
21.07.22
€345.60
Summary
This prediction ended on 21.07.22 with a price of €345.60. The price of Genmab A/S has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.86%. Lars has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genmab A/S | -3.253% | -3.253% | 26.558% | -30.967% |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by Lars for this prediction
In the thread Genmab A/S diskutieren
Lars hat das Wertpapier Genmab A/S in seinem Wikifolio Wikifolio WF00074737 von Lars gekauft.